Biomarker discovery and validation

Biomarkers play a pivotal role across multiple research areas because of their potential to allow us to predict, diagnose, or monitor disease. There is still a significant need for biomarkers that detect diseases where early diagnosis is crucial or difficult. However, continuing research in this field offers hope for new biomarkers as well as increased validation and applications of current biomarkers to improve diagnostics and therapeutics for many diseases.  

In oncology, the impact of biomarkers on the progression and implementation of the research of certain cancers through new biomarker discovery and validation across different cancer types and stages, as well as target prioritization for translation to preclinical research, has been immense.  

Whether it’s identifying the right targets, our extensive antibody validation for immunohistochemistry, or collaborating with key industry leaders to bring you the latest insights from the industry, we are dedicated to supporting your next biomarker discovery.